Type
. Management of Leprosy Patients in the Era of COVID19. Dermatologic therapy [Internet]. 2020;:e13631. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1111/dth.13631
Type
. Leprosy in the twenty-first century: a microbiological, clinical, and epidemiological study in northwestern Spain. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2020;.
Type
. Surveillance of Leprosy in Kiribati, 1935-2017. Emerging infectious diseases [Internet]. 2020;26(5):833-840. Available from: https://wwwnc.cdc.gov/eid/article/26/5/18-1746_article
Type
. Diagnostic accuracy of tests using recombinant protein antigens of Mycobacterium leprae for leprosy: A systematic review. Journal of infection and public health [Internet]. 2020;. Available from: https://www.sciencedirect.com/science/article/pii/S187603412030397X?via%3Dihub
Type
. Use of methotrexate for leprosy reactions. Experience of a referral center and systematic review of the literature. Travel medicine and infectious disease. 2020;:101670.
Type
. [The use of synthetic glycoconjugates as components of the immunochromatographic test for rapid serological diagnosis of leprosy.]. Klinicheskaia laboratornaia diagnostika. 2020;65(5):289-293.
Type
. Leprosy in a low-incidence setting : Case report relevant to metagenomic next generation sequencing applications. Wiener klinische Wochenschrift. 2020;.
Type
. Leprosy: Treatment and Management of Complications. Journal of the American Academy of Dermatology. 2020;.
Type
. Leprosy: Why does it persist among us?. Expert review of anti-infective therapy. 2020;.
Type
. Leprosy: Treatment and Management of Complications. Journal of the American Academy of Dermatology. 2020;.